Literature DB >> 15562950

Defective interleukin-2 production and interleukin-2 receptor expression in pulmonary tuberculosis.

Madhu Khanna1, L M Srivastava, Pankaj Kumar.   

Abstract

The evolution of Mycobacterium tuberculosis as an intracellular pathogen has led to a complex relationship between it and its host, the human mononuclear phagocyte. The products of M. tuberculosis-specific T lymphocytes are essential for macrophage activation for intracellular mycobacterial killing. However, dysfunction cell-mediated immune response to infection with M. tuberculosis may contribute to progressive primary infection or reactivation of endogenous foci of mycobacteria. Th1 cells produce IL-2, which is essential for proper cellular immunity. The aim of this study was to identify the variation in IL-2 activity and soluble IL-2 receptor (IL-2 R) in peripheral blood lymphocyte in patients suffering with pulmonary tuberculosis. A significant decrease in IL-2 and IL-2 receptor level was observed in patients with pulmonary tuberculosis when compared to normal controls. Our results suggested that patients with pulmonary tuberculosis had a defect in IL-2 production. Better understanding of these interactions will allow the development of increasingly specific immune-based interventions for prevention and treatment of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15562950

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  2 in total

1.  Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth.

Authors:  Patricia L Semple; Marcia Watkins; Virginia Davids; Alan M Krensky; Willem A Hanekom; Gilla Kaplan; Stanley Ress
Journal:  Clin Dev Immunol       Date:  2010-12-28

2.  Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population.

Authors:  Mariana Milano; Milton Ozório Moraes; Rodrigo Rodenbusch; Caroline Xavier Carvalho; Melaine Delcroix; Gabriel Mousquer; Lucas Laux da Costa; Gisela Unis; Elis Regina Dalla Costa; Maria Lucia Rosa Rossetti
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.